An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.
The rate of Alzheimer's disease and other dementias is falling in the United States and some other rich countries -- good news about an epidemic that is still growing simply because more people are living to an old age, new studies show.
By the time Alzheimer’s symptoms rear their head, brain degeneration is often irreparable. But while the disease has no cure, simple eye tests and smell tests could be used to catch the risks early, according to new research.
In one of the most ambitious attempts yet to thwart Alzheimer's disease, a major study is underway to see if an experimental drug can protect healthy seniors whose brains harbour silent signs that they're at risk.
Can old drugs provide new hope in the fight against Alzheimer’s disease? While most drugs developed to treat the disease have proven unsuccessful, research suggests some existing, tried-and-true medications used to treat high blood pressure may offer some protection.
Alzheimer’s disease may contribute to nearly as many deaths as heart disease and cancer, according to a new study, which found that deaths from the disease in the United States were much higher than reported.